Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China · Delayed Price · Currency is CNY 10.07
+0.10 (1.00%)
May 19, 2026, 10:25 AM CST
SHE:300439 Revenue
Medicalsystem Biotechnology had revenue of 376.02M CNY in the quarter ending March 31, 2026, with 0.53% growth. This brings the company's revenue in the last twelve months to 1.54B, down -5.74% year-over-year. In the year 2025, Medicalsystem Biotechnology had annual revenue of 1.54B, down -11.67%.
Revenue (ttm)
1.54B
Revenue Growth
-5.74%
P/S Ratio
2.49
Revenue / Employee
732.49K
Employees
2,104
Market Cap
3.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.54B | -203.26M | -11.67% |
| Dec 31, 2024 | 1.74B | -143.44M | -7.61% |
| Dec 31, 2023 | 1.89B | -603.22M | -24.23% |
| Jan 1, 2023 | 2.49B | 237.55M | 10.55% |
| Dec 31, 2021 | 2.25B | -50.50M | -2.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maccura Biotechnology Co.Ltd | 2.14B |
| Shanghai Labway Clinical Laboratory | 1.38B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Amoy Diagnostics | 1.19B |
| Thalys Medical Technology Group | 971.32M |
| Berry Genomics Co.,Ltd | 922.27M |
| SMO ClinPlus CO.,LTD. | 860.07M |
| Guangdong Hybribio Biotech | 669.64M |